Surgical treatment for adult spinal deformity: projected cost effectiveness at 5-year follow-up
- PMID: 24688328
- PMCID: PMC3962303
Surgical treatment for adult spinal deformity: projected cost effectiveness at 5-year follow-up
Abstract
Background: In the United States, expenditures related to spine care are estimated to account for $86 billion annually. Policy makers have set a cost-effectiveness benchmark of less than $100,000/quality adjusted life year (QALY), forcing surgeons to defend their choices economically. This study projects the cost/QALY for surgical treatment of adult spinal deformity at 5-year follow-up based on 2-year cost- and health-related quality-of-life (HRQOL) data.
Methods: In a review of 541 patients with adult spinal deformity, the patients who underwent revision or were likely to undergo revision were identified and cost of surgery was doubled to account for the second procedure; all other patients maintained the cost of the initial surgery. Oswestry Disability Index (ODI) was modeled by revision status based on literature findings. Total surgical cost was based on Medicare reimbursement. Chi square and student t tests were utilized to compare cost-effective and non-cost-effective patients.
Results: The average cost/QALY at 5-year follow-up was $120,311.73. A total of 40.7% of patients fell under the threshold of a cost/QALY <$100,000. Cost-effective patients had higher baseline ODI scores (45% vs 34% [P=0.001]), lower baseline total Scoliosis Research Society scores (2.89 vs 3.00 [P=0.04]), and shorter fusions (8.23 vs 9.87 [P=0.0001]).
Conclusion: We found 40.7% of patients to be below the threshold of cost effectiveness. Factors associated with reaching the threshold <$100,000/QALY were greater preoperative disability, diagnosis of idiopathic scoliosis, poor preoperative HRQOL scores, and fewer fusion levels.
Keywords: Cost-benefit analysis; quality adjusted life years; quality of life; scoliosis; spine; surgical procedures–operative.
Conflict of interest statement
References
-
- Anderson GF, Hussey PS, Frogner BK, Waters HR. Health spending in the United States and the rest of the industrialized world. Health Aff (Millwood) 2005 Jul-Aug;24(4):903–914. - PubMed
-
- Chapman JE, Jr, Sinicrope RA, Clark DM. Angio and peritoneal access for endstage renal disease in the community hospital: a cost analysis. Am Surg. 1986 Jun;52(6):315–319. - PubMed
-
- Kindlmann GL, Weinstein DM, Jones GM, Johnson CR, Capecchi MR, Keller C. Practical vessel imaging by computed tomography in live transgenic mouse models for human tumors. Mol Imaging. 2005 Oct-Dec;4(4):417–424. - PubMed
-
- Martin BI, Turner JA, Mirza SK, Lee MJ, Comstock BA, Deyo RA. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006. Spine (Phila Pa 1976) 2009 Sep 1;34(19):2077–2084. - PubMed
-
- Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008 Feb 13;299(6):656–664. Erratum in: JAMA. 2008 Jun 11;299(22):2630. - PubMed
LinkOut - more resources
Full Text Sources